Fox Health: 19 drug approvals in 2024 that had 'big clinical impact,' according to GoodRx

[riky]

19 drug approvals in 2024 that had 'big clinical impact,' according to GoodRx

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of conditions. These medications are "slated to make a big clinical impact."...                        ...                        ...                            ...2024 brought some major You are not allowed to view links. Register or Login......That includes the approval of "innovative" drugs like Tryvio for high blood pressure, Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all gained FDA approval this year.......You are not allowed to view links. Register or Login are "slated to make a big clinical impact for those who need them," according to GoodRx, a California-based digital health care platform.......You are not allowed to view links. Register or Login......Earlier this month, GoodRx released a list of the 19 most influential drug and You are not allowed to view links. Register or Login of 2024, some newly designed to treat certain conditions and other existing medications that were approved for additional uses.......Here is the list in order of FDA approval date.......1. Dupixent – Additional use: Eosinophilic esophagitis (an allergic condition that causes inflammation of the esophagus)......2. Amtagvi – New medication: You are not allowed to view links. Register or Login......3. Xolair – Additional use: Food allergies......You are not allowed to view links. Register or Login......4. Wegovy – Additional use: You are not allowed to view links. Register or Login......5. Tryvio – New medication: High blood pressure......6. Nexletol – Additional use: High cholesterol......7. Winrevair – New medication: Pulmonary arterial hypertension......8. mRESVIA – New vaccine: RSV......9. Capvaxive – New vaccine: Pneumococcal disease......10. Wakix – Additional use: Pediatric narcolepsy......You are not allowed to view links. Register or Login......11. Ohtuvayre – New medication: COPD......12. Kisunla – New medication: You are not allowed to view links. Register or Login......13. Voquezna – Additional use: Heartburn from non-erosive GERD (gastroesophageal reflux disease)......14. Zunveyl – New medication: Alzheimer's disease......15. Yorvipath – New medication: Hypoparathyroidism (low levels of the parathyroid hormone)......You are not allowed to view links. Register or LoginYou are not allowed to view links. Register or Login......16. Neffy – New medication: Severe You are not allowed to view links. Register or Login......17. FluMist – Additional use: Self- or caregiver-administration ......You are not allowed to view links. Register or Login......18. Cobenfy – New medication: Schizophrenia......19. Dupixent – Additional use: COPD......In a disclaimer, GoodRx noted that the list was created by prioritizing "first-in-class medications and vaccines that are expected to have a significant impact on You are not allowed to view links. Register or Login."......"This was defined as either the number of lives touched or the expected degree of impact for future medication recipients," the company wrote. ......"We also prioritized medications with effectiveness or safety data that represent a notable advantage over other medications recommended by clinical treatment guidelines or mainstay medical organizations."......Fox News Digital reached out to GoodRx for comment....

Source: You are not allowed to view links. Register or Login